Startseite Crystal structure of (E)-7-fluoro-2-(4-morpholinobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C21H20FNO2
Artikel Open Access

Crystal structure of (E)-7-fluoro-2-(4-morpholinobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C21H20FNO2

  • Han-Lin Luo , Wen-Xuan Li , Xian-Yong Bai , Qing-Guo Meng und Yun Hou ORCID logo EMAIL logo
Veröffentlicht/Copyright: 14. März 2023
Artikel downloaden (PDF)
Veröffentlichen auch Sie bei De Gruyter Brill
Manuskript einreichen Informationen für Autor*innen
Zeitschrift für Kristallographie - New Crystal Structures
Aus der Zeitschrift Zeitschrift für Kristallographie - New Crystal Structures Band 238 Heft 3

Abstract

C 21 H 20 F N O 2 , triclinic, P1̄ (no. 2), a = 9.2201(7) Å, b = 9.3195(8) Å, c = 11.4012(9) Å, α =  103.880 ( 7 ) ° , β =  100.987 ( 7 ) ° , γ =  115.090 ( 7 ) ° , V = 1796.31(20)  Å 3 , Z = 2, R g t (F) = 0.0421, w R r e f ( F 2 ) = 0.1136, T = 293 K.

CCDC no.: 2213130

The crystal structure is shown in the Figure. Displacement ellipsoids are drawn at the 30% probability level.

Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Colourless block
Size: 0.12 × 0.12 × 0.10 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 0.10 mm−1
Diffractometer, scan mode: SuperNova
θ max, completeness: 25.5°, >99%
N(hkl)measured , N(hkl)unique, R int: 5331, 3015, 0.025
Criterion for I obs, N(hkl)gt: I obs > 2σ(I obs), 2363
N(param)refined: 227
Programs: CrysAlis PRO [1], SHELX [2, 3]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z U iso*/U eq
C1 0.56397 (17) 1.19487 (19) 0.63909 (14) 0.0264 (3)
C2 0.40275 (17) 1.08726 (18) 0.65534 (14) 0.0268 (3)
C3 0.24048 (17) 1.01839 (19) 0.54719 (15) 0.0295 (4)
H3A 0.145851 0.984535 0.579472 0.035*
H3B 0.222835 0.918155 0.482222 0.035*
C4 0.24340 (17) 1.14812 (19) 0.48648 (15) 0.0310 (4)
H4A 0.146647 1.091689 0.408305 0.037*
H4B 0.231542 1.234177 0.544562 0.037*
C5 0.40381 (18) 1.2947 (2) 0.35557 (15) 0.0335 (4)
H5 0.301791 1.274575 0.302513 0.040*
C6 0.55297 (19) 1.3851 (2) 0.33312 (15) 0.0359 (4)
H6 0.552333 1.425014 0.265812 0.043*
C7 0.70260 (17) 1.41380 (19) 0.41397 (15) 0.0301 (4)
C8 0.70804 (17) 1.35272 (18) 0.51109 (14) 0.0278 (4)
H8 0.810702 1.372226 0.562599 0.033*
C9 0.55638 (16) 1.26018 (17) 0.53188 (14) 0.0246 (3)
C10 0.40287 (17) 1.23331 (18) 0.45558 (14) 0.0272 (3)
C11 0.41659 (18) 1.06564 (19) 0.76909 (15) 0.0290 (4)
H11 0.527895 1.120775 0.824305 0.035*
C12 0.29142 (18) 0.97297 (19) 0.82209 (14) 0.0284 (3)
C13 0.33310 (18) 1.03022 (19) 0.95568 (14) 0.0312 (4)
H13 0.438261 1.124989 1.005246 0.037*
C14 0.22585 (17) 0.95279 (19) 1.01631 (14) 0.0310 (4)
H14 0.257798 0.998772 1.105025 0.037*
C15 0.06777 (17) 0.80456 (18) 0.94679 (14) 0.0265 (3)
C16 0.02699 (18) 0.74408 (18) 0.81312 (14) 0.0295 (4)
H16 −0.075580 0.645934 0.763587 0.035*
C17 0.13453 (17) 0.82593 (19) 0.75324 (14) 0.0299 (4)
H17 0.101848 0.782103 0.664372 0.036*
C18 −0.01093 (18) 0.81091 (19) 1.14081 (14) 0.0315 (4)
H18A −0.050767 0.892291 1.143258 0.038*
H18B 0.109467 0.873045 1.189358 0.038*
C19 −0.10442 (19) 0.6894 (2) 1.20107 (16) 0.0427 (4)
H19A −0.055334 0.616601 1.207199 0.051*
H19B −0.089887 0.753469 1.287273 0.051*
C20 −0.2997 (2) 0.4894 (2) 1.00609 (17) 0.0417 (4)
H20A −0.419576 0.415885 0.957357 0.050*
H20B −0.249243 0.417988 1.013519 0.050*
C21 −0.21681 (18) 0.6007 (2) 0.93542 (16) 0.0386 (4)
H21A −0.227185 0.529976 0.853037 0.046*
H21B −0.275024 0.663445 0.920018 0.046*
F1 0.85045 (10) 1.50772 (11) 0.39625 (10) 0.0426 (3)
N1 −0.03751 (14) 0.71990 (15) 1.00812 (11) 0.0294 (3)
O1 0.70278 (12) 1.23344 (15) 0.71052 (11) 0.0407 (3)
O2 −0.28086 (13) 0.58668 (15) 1.13005 (11) 0.0442 (3)

1 Source of material

The intermediate 7-fluoro-3,4-dihydronaphthalen-1(2H)-one was synthesized in accordance with the literature synthesis approach [4]. In a 50 mL spherical backside flask, 7-fluoro-3,4-dihydronaphthalen-1(2H)-one (1.00 g, 6.09 mmol) and 4-morpholinobenzaldehyde (1.16 g, 6.09 mmol) were dissolved in 10 mL of methanol under an ice-cold salt tub at 268 K. Add 5 mL of 25% NaOH aqueous solution dropwise, and the gadget turns into turbid after 5 min with a white precipitate. The response used to be monitored through thin-layer chromatography (TLC, Dichloromethane:Methanol = 40:1), v/v. At the stop of the reaction, the mixture were once filtered, and the filter residue used to be washed in three instances with 50% aqueous methanol. The title compound, 7-fluoro-2-(4-morpholinobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, was purified with the aid of silica gel column chromatography (Dichloromethane:Methanol = 20:1), v/v to acquire colourless crystals.

2 Experimental details

The H atoms were placed in idealized positions and treated as riding on their parent atoms, with d (C–H) = 0.97 Å (methylene), U i s o (H) = 1.2 U e q (C), and d (C–H) = 0.93 Å (aromatic), U i s o (H) = 1.2 U e q (C).

3 Comment

Recently, 3,4-dihydronaphthalen-1(2H)-one derivatives (DHNs) were reported to improve their toxicity and anti-neuroinflammatory effects [5]. The substituents of some DHNs include halogens, methoxies, substituted phenyl groups, aromatic heterocycles and so on. Therein, methoxy-substituted DHN derivative showed lower toxicity and more potential anti-neuroinflammatory effects through inhibiting the activation of NF-κB signaling pathway [6]. For further structural optimization, a morpholine ring was added to the aromatic ring of DHNs in this experiment, and the title compound was synthesized by the Claisen–Schmidt condensation reaction between 7-fluoro-3,4-dihydronaphthalen-1(2H)-one and 4-morpholinobenzaldehyde.

Single-crystal structure analysis reveals that there is one DHN molecule in the asymmetric unit (cf. the Figure). Bond lengths and angles are all in the expected ranges. The 7 position of 3,4-dihydronaphthalen-1(2H)-one is substituted by electron-withdrawing fluorine substituent. The fluorine atom can act as a hydrogen bonding acceptor [7]. Through the Claisen–Schmidt condensation reaction between 3,4-dihydronaphthalen-1(2H)-one and aromatic aldehydes, the title compound formed α, β– unsaturated ketone structural characteristic. It adopts the E stereochemistry of the olefinic double bond [8, 9]. The bond length of C(2) = C(11) bonds is 1.350(2) Å, which is consistent with the range of bond lengths of olefinic bonds. The torsion angle of C(1)–C(2)–C(11)–C(12) is 179.24 ( 14 ) ° , while the torsion angle of C(3)–C(2)–C(11)–C(12) is 1.6 ( 3 ) ° . In addition, two methylene groups affect the molecular coplanarity resulting in a certain amount of distortion between the 4-morpholinophenyl ring and 3,4-dihydronaphthalen-1(2H)-one. Their dihedral angle is about 45.72 ( 2 ) ° . At the end of the title compound, there is 4-morpholino substituent, which exhibits “chair” conformation [10]. The distance of N(1)–O(2) is 2.857(3) Å. The torsion angle of O(2)–C(19)–C(18)–N(1) is 55.64 ( 17 ) ° , while the torsion angle of O(2)–C(20)–C(21)–N(1) is 56.09 ( 17 ) ° . In general, the entire molecule forms a linear structure [11, 12].

Corresponding author: Yun Hou, School of Basic Medical Sciences, Binzhou Medical University, Yantai, 264003, P. R. China, E-mail:

Funding source: Science and Technology Innovation Development Plan of Yantai

Award Identifier / Grant number: 2022XDRH003

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work was supported by Science and Technology Innovation Development Plan of Yantai (No. 2022XDRH003) and Key support projects (inheritance and development of traditional Chinese Medicine) of the State Administration of traditional Chinese medicine.

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Rigaku, O. D. CrysAlisPRO; Rigaku Oxford Diffraction Ltd: Yarnton, Oxfordshire, England, 2017.Suche in Google Scholar

2. Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. 2008, A64, 112–122; https://doi.org/10.1107/s0108767307043930.Suche in Google Scholar PubMed

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar

4. Zhang, X.-F., Luan, M.-Z., Yan, W.-B., Zhao, F.-L., Hou, Y., Hou, G.-G., Meng, Q.-G. Anti-neuroinflammatory effects of novel 5,6-dihydrobenzo[h] quinazolin-2-amine derivatives in lipopolysaccharide-stimulated BV2 microglial cells. Eur. J. Med. Chem. 2022, 213, 114322; https://doi.org/10.1016/j.ejmech.2022.114322.Suche in Google Scholar PubMed

5. Nelson, K. M., Dahlin, J. L., Bisson, J., Graham, J., Pauli, G. F., Walters, M. A. The essential medicinal chemistry of curcumin. J. Med. Chem. 2017, 60, 1620–1637; https://doi.org/10.1021/acs.jmedchem.6b00975.Suche in Google Scholar PubMed PubMed Central

6. Sun, Y., Zhou, Y. Q., Liu, Y. K., Zhang, H. Q., Hou, G. G., Meng, Q. G., Hou, Y. Potential anti-neuroinflammatory NF-κB inhibitors based on 3,4-dihydronaphthalen-1(2H)-one derivatives. J. Enzym. Inhib. Med. Chem. 2020, 35, 1631–1640; https://doi.org/10.1080/14756366.2020.1804899.Suche in Google Scholar PubMed PubMed Central

7. Swallow, S. Fluorine in medicinal chemistry. Prog. Med. Chem. 2015, 54, 65–133; https://doi.org/10.1016/bs.pmch.2014.11.001.Suche in Google Scholar PubMed

8. Zhang, Y.-L., Liu, S.-L., Hou, G.-G., Wang, L., Zhang, X.-F. Crystal structure of (E)-7-bromo-2-(3,5-dimethoxybenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C19H17BrO3. Z. Kristallogr. N. Cryst. Struct. 2022, 237, 907–909; https://doi.org/10.1515/ncrs-2022-0316.Suche in Google Scholar

9. Zhang, Y.-L., Liu, S.-L., Hou, G.-G., Zhang, X.-F., Wang, L., Xin, W.-Y. Crystal structure of (E)-7-bromo-2-(4-methoxybenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C18H15BrO2. Z. Kristallogr. N. Cryst. Struct. 2022, 237, 945–947; https://doi.org/10.1515/ncrs-2022-0315.Suche in Google Scholar

10. Yuan, X.-Q., Zhao, L.-H., Zhang, J.-J., Hou, G.-G. Crystal structure of (E)-7-methoxy-2-(4-morpholinobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C22H23NO3. Z. Kristallogr. N. Cryst. Struct. 2023, 238, 363–365. https://doi.org/10.1515/NCRS-2022–0578.10.1515/ncrs-2022-0578Suche in Google Scholar

11. Wang, L., Meng, Q.-G., Hou, G.-G. Crystal structure of (E)-7-methoxy-2-((6-methoxypyridin-2-yl) methylene)-tetralone, C18H17NO3. Z. Kristallogr. N. Cryst. Struct. 2021, 236, 1023–1025; https://doi.org/10.1515/ncrs-2021-0207.Suche in Google Scholar

12. Song, J., Zhao, F.-L., Wang, Q.-b., Meng, Q.-G. Crystal structure of (E)-7-fluoro-2-(3-fluorobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C17H12F2O1. Z. Kristallogr. N. Cryst. Struct. 2022, 237, 55–57; https://doi.org/10.1515/ncrs-2021-0392.Suche in Google Scholar
Received: 2023-02-06
Accepted: 2023-02-26
Published Online: 2023-03-14
Published in Print: 2023-06-27

© 2023 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of phenyl(3,3-dichloro-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one)methanone, C7H4Cl2N2O
  4. Crystal structure of poly[diaqua-bis(μ 2-1,4-diaminobutane-N:N′)cobalt(II)] dichloride, C8H28Cl2CoN4O2
  5. Synthesis and crystal structure of (4aR,7S)-7-hydroxy-7-isopropyl-1,1-dimethyldecahydro-2H,6H-8a,4a-(epoxymethano)phenanthren-12-one, C20H32O3
  6. The crystal structure of 1-(2-chlorobenzyl)-3-(3,5-dichlorophenyl)urea, C14H11Cl3N2O
  7. Crystal structure of tetrapropylammonium-1,3,5-thiadiazole-5-amido-2-carbamate – 1,2,4-thiadiazole-3,5-diamine – water (1/1/1), C17H37N9O3S2
  8. Tetrabutylammonium 1,3,5-thiadiazole-5-amido-2-carbamate—1,2,4-thiadiazole-3,5-diamine— water (1/1/1), C21H45N9O3S2
  9. The crystal structure of ((E)-2,4-dichloro-6-(((2-hydroxy-5-nitrophenyl)imino)methyl)phenolato-κ 3 N,O,O′)tris(pyridine-κN)manganese(II), C28H21Cl2MnN5O4
  10. The crystal structure of aqua-bis{2-bromo-6-((2-(2-phenylacetyl)hydrazineylidene)methyl)phenolato-κ3 N,O,O′}-dimethylformamide-κ1 O-erbium(III) chloride – dimethylformamide – water (1/2/1), C39H49N7O9Br2ClEr
  11. Crystal structure of (diaqua-bis(phenanthroline-K 2 N,N′)-tetrakis(m 2-3,4,5,6-tetrafluorophthalato-K 4 O,O:O′:O″;K 2 O:O′)dierbium (III) phenanthroline (1/2), C80H38Er2F16N8O18
  12. Crystal structure of (E)-7-methoxy-2-(4-methoxy-2-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C20H17F3O3
  13. The crystal structure of 4–(4,4,5,5–tetramethyl–1,3,2–dioxaborolan–2–yl)morpholine, C10H20BNO3
  14. The crystal structure of catena–poly[aqua(1-naphthoato-κ 2 O,O′)-(μ-1-naphthoato-κ 4 O:O,O′:O′)lead(II)], C22H16O5Pb
  15. The crystal structure of 1-(4-chlorophenyl)-3-cycloheptylurea, C14H19ClN2O
  16. The crystal structure of 4-(pyren-1-yl)butyl-4-nitrobenzoate, C27H21NO4
  17. Crystal structure of cyclo-(bis(µ2-3,3′-(1H-imidazole-3-ium-1,3-diyl)dipropionato-κ4 O,O′:O″,O″′)-dinitrato-κ2 O,O′-tetraoxido-diuranium(VI) C18H22N6O18U2
  18. The crystal structure of catena-[nitrato-κ 2 O,O′-(μ 3-3-iodobenzene-1,2-dicarboxylato-κ 4 O:O′:O″,O‴)-(2,2′:6′,2″-terpyridine-κ 3 N,N′,N″)lanthanum(III)], C23H14IN4O7La
  19. Redetermination of crystal structure of [bis(pyridin-2-ylmethyl)amine-κ 3 N,Nʹ,Nʺ]chloridopalladium(II) chloride monohydrate
  20. Crystal structure of catena-poly[triaqua-[bis(m2-4-(1H-1,2,4-triazol-1-yl)benzoato-k2O:O')-(4-(1H-1,2,4-triazol-1-yl)benzoato-k1O)-praseodymium (III) monohydrate], C27H26N9O10Pr
  21. Crystal structure of trans-diaqua-bis(methyl methylcarbamohydrazonothioato-κ2 N,N′) nickel(II) iodide semihydrate, C6H22N6O2NiS2I2·0.5H2O
  22. The crystal structure of 2-(2-fluoro-4-methyl-5-((2,2,2-trifluoroethyl)thio)phenyl)isoindolin-1-one, C17H13F4NOS
  23. The crystal structure of di-μ-1-naphthylacetato-κ 3 O,O′:O;κ 3 O:O,O′-bis[(1-naphthylacetato-κ 2 O,O′)(2,2′-bipyridine-κ 2 N,N′)lead(II)] monohydrate, C68H54N4O9Pb2
  24. Crystal structure of tetrapropylammonium guanidinium 4,4′-sulfonyldibenzoate monohydrate, C27H44N4O7S
  25. Crystal structure of bis(tetrapropylammonium) terephthalate – 1-(diaminomethylene)thiourea – water (1/2/4) C18H40N5O4S
  26. Crystal structure of (E)-7-fluoro-2-(4-morpholinobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C21H20FNO2
  27. The crystal structure of poly[diaqua-bis(μ 3-5-bromobenzene-1,3-dicarboxylato-κ 3 O,O,O′)-(μ 2-1,3-bis-(4-pyridyl)-propane-κ 2 N,N′)-dizinc(II))] – 5-bromobenzene-1,3-dicarboxylic acid [2/1], C37H29Br3N2O14Zn2
  28. The crystal structure of 2-bromo-1,3-phenylene bis(4-methylbenzenesulfonate), C20H17BrO6S2
  29. Crystal structure of europium dichromium icosaaluminum, EuCr2Al20
  30. The crystal structure of N′1,N′3-di((E)-benzylidene) isophthalohydrazide dihydrate, C 22 H 22 N 4 O 4
  31. Crystal structure of 7α,11α-dihydroxy-15-oxo-ent-kauran-16-en-19,6β-olide, C20H26O5
  32. Crystal structure of 4-chloro-N′-[(1E)-pyridin-3-ylmethylidene]benzohydrazide, C13H10ClN3O
  33. The crystal structure of (Z)-3-(1-(2-((E)-4-isopropylbenzylidene)hydrazinyl)ethylidene) chroman-2,4-dione, C21H20N2O3
  34. Crystal structure of E-7-fluoro-2-(2-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C18H12F4O
  35. Crystal structure of bis(6-aminopyridine-2-carboxylato–k2O,N)-bis(N,N-dimethylformamide-k1 O)zinc(II), C18H24N6O6Zn
  36. Crystal structure of 5-(adamantan-1-yl)-3-[(4-{[2-(trifluoromethyl)phenyl]-methyl}piperazin-1-yl)methyl]-1,3,4-oxadiazole-2(3H)-thione, C25H31F3N4OS
  37. Crystal structure of tetrapropylammonium bicarbonate–1-(diaminomethylene)thiourea – water (2/2/1), C30H72N10O7S2
  38. Crystal structure of tris(2,2′-bipyridine-κ2 N,N′)iron(II) triiodide – dichloromethane (2/1), C61H50Cl2Fe2I12N12
  39. Crystal structure of 2-amino-3-[2-(1,3,3-trimethyl-1,3-dihydro-indol-2-ylidene)-ethylideneamino]-but-2-enedinitrile, C17H17N5
  40. The crystal structure of 1-(2-chlorophenyl)-3-cycloheptylurea, C14H19ClN2O
  41. Crystal structure of potassium bis(pentaselenido-κ 2 Se 1,Se 5)palladate(II), K2[Pd(Se5)2]
  42. The crystal structure of 5,10-bis(2-methoxyethyl)-5,10-dihydro-[1,2,3,4]tetrathiocino[5,6-b:8, 7-b′]diindole, C22H22N2O2S4
  43. The crystal structure of 4-(4-iodophenyl)-5H-1,2,3-dithiazole-5-thione, C8H4INS3
  44. Crystal structure of bis{μ2-(4-acetyl-phenoxy)acetato-κ2 O:O′}-bis{μ2-(4-acetyl-phenoxy)acetato-κ3 O,O′:O)- bis{(4-acetyl-phenoxy)acetato-κ2 O,O′}-bis(phenanthrolin-κ2 N,N′)didysprosium(III) tetrahydrate, C84H78N4O28Dy2
  45. Crystal structure of Eu2Pd3.37(1)Zn13.63(1)
  46. Crystal structure of 2-methoxy-4-(methoxy-carbonyl)phenyl 2-chloro-4-fluorobenzoate, C16H12ClFO5
  47. Crystal structure of catena-poly[bis(μ2-dicyanamide-κ2 N:N′)-bis(4-vinylpyridine-κN)-copper(II)], C18H14CuN8
  48. The crystal structure of iguratimod-dimethylformamide (1/1), C17H14N2O6S·C3H7NO
  49. Synthesis and crystal structure of 1-((3R,10S,13S,17S)-10,13-dimethyl-3-(m-tolylamino)hexadecahydro-1H-cyclopenta[α]phenanthren-17-yl)ethan-1-one, C28H41NO
  50. The crystal structure of diaqua-bis(4-bromo-2-formylphenoxy)zinc(II), C14H12Br2O6Zn
  51. The crystal structure of tetra(1-ethylimidazole-κ 1 N)-[μ 4-imidazole-4,5-dicarboxylato-κ 4 O, N, O′, N′]-trioxido-divanadium, C25H33N10O7V2
  52. The crystal structure of (E)-N′-(1-(4-fluorophenyl)propylidene)-2-hydroxybenzohydrazide, C16H15FN2O2
https://doi.org/10.1515/ncrs-2023-0053
Creative Commons
BY 4.0

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of phenyl(3,3-dichloro-1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one)methanone, C7H4Cl2N2O
  4. Crystal structure of poly[diaqua-bis(μ 2-1,4-diaminobutane-N:N′)cobalt(II)] dichloride, C8H28Cl2CoN4O2
  5. Synthesis and crystal structure of (4aR,7S)-7-hydroxy-7-isopropyl-1,1-dimethyldecahydro-2H,6H-8a,4a-(epoxymethano)phenanthren-12-one, C20H32O3
  6. The crystal structure of 1-(2-chlorobenzyl)-3-(3,5-dichlorophenyl)urea, C14H11Cl3N2O
  7. Crystal structure of tetrapropylammonium-1,3,5-thiadiazole-5-amido-2-carbamate – 1,2,4-thiadiazole-3,5-diamine – water (1/1/1), C17H37N9O3S2
  8. Tetrabutylammonium 1,3,5-thiadiazole-5-amido-2-carbamate—1,2,4-thiadiazole-3,5-diamine— water (1/1/1), C21H45N9O3S2
  9. The crystal structure of ((E)-2,4-dichloro-6-(((2-hydroxy-5-nitrophenyl)imino)methyl)phenolato-κ 3 N,O,O′)tris(pyridine-κN)manganese(II), C28H21Cl2MnN5O4
  10. The crystal structure of aqua-bis{2-bromo-6-((2-(2-phenylacetyl)hydrazineylidene)methyl)phenolato-κ3 N,O,O′}-dimethylformamide-κ1 O-erbium(III) chloride – dimethylformamide – water (1/2/1), C39H49N7O9Br2ClEr
  11. Crystal structure of (diaqua-bis(phenanthroline-K 2 N,N′)-tetrakis(m 2-3,4,5,6-tetrafluorophthalato-K 4 O,O:O′:O″;K 2 O:O′)dierbium (III) phenanthroline (1/2), C80H38Er2F16N8O18
  12. Crystal structure of (E)-7-methoxy-2-(4-methoxy-2-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C20H17F3O3
  13. The crystal structure of 4–(4,4,5,5–tetramethyl–1,3,2–dioxaborolan–2–yl)morpholine, C10H20BNO3
  14. The crystal structure of catena–poly[aqua(1-naphthoato-κ 2 O,O′)-(μ-1-naphthoato-κ 4 O:O,O′:O′)lead(II)], C22H16O5Pb
  15. The crystal structure of 1-(4-chlorophenyl)-3-cycloheptylurea, C14H19ClN2O
  16. The crystal structure of 4-(pyren-1-yl)butyl-4-nitrobenzoate, C27H21NO4
  17. Crystal structure of cyclo-(bis(µ2-3,3′-(1H-imidazole-3-ium-1,3-diyl)dipropionato-κ4 O,O′:O″,O″′)-dinitrato-κ2 O,O′-tetraoxido-diuranium(VI) C18H22N6O18U2
  18. The crystal structure of catena-[nitrato-κ 2 O,O′-(μ 3-3-iodobenzene-1,2-dicarboxylato-κ 4 O:O′:O″,O‴)-(2,2′:6′,2″-terpyridine-κ 3 N,N′,N″)lanthanum(III)], C23H14IN4O7La
  19. Redetermination of crystal structure of [bis(pyridin-2-ylmethyl)amine-κ 3 N,Nʹ,Nʺ]chloridopalladium(II) chloride monohydrate
  20. Crystal structure of catena-poly[triaqua-[bis(m2-4-(1H-1,2,4-triazol-1-yl)benzoato-k2O:O')-(4-(1H-1,2,4-triazol-1-yl)benzoato-k1O)-praseodymium (III) monohydrate], C27H26N9O10Pr
  21. Crystal structure of trans-diaqua-bis(methyl methylcarbamohydrazonothioato-κ2 N,N′) nickel(II) iodide semihydrate, C6H22N6O2NiS2I2·0.5H2O
  22. The crystal structure of 2-(2-fluoro-4-methyl-5-((2,2,2-trifluoroethyl)thio)phenyl)isoindolin-1-one, C17H13F4NOS
  23. The crystal structure of di-μ-1-naphthylacetato-κ 3 O,O′:O;κ 3 O:O,O′-bis[(1-naphthylacetato-κ 2 O,O′)(2,2′-bipyridine-κ 2 N,N′)lead(II)] monohydrate, C68H54N4O9Pb2
  24. Crystal structure of tetrapropylammonium guanidinium 4,4′-sulfonyldibenzoate monohydrate, C27H44N4O7S
  25. Crystal structure of bis(tetrapropylammonium) terephthalate – 1-(diaminomethylene)thiourea – water (1/2/4) C18H40N5O4S
  26. Crystal structure of (E)-7-fluoro-2-(4-morpholinobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C21H20FNO2
  27. The crystal structure of poly[diaqua-bis(μ 3-5-bromobenzene-1,3-dicarboxylato-κ 3 O,O,O′)-(μ 2-1,3-bis-(4-pyridyl)-propane-κ 2 N,N′)-dizinc(II))] – 5-bromobenzene-1,3-dicarboxylic acid [2/1], C37H29Br3N2O14Zn2
  28. The crystal structure of 2-bromo-1,3-phenylene bis(4-methylbenzenesulfonate), C20H17BrO6S2
  29. Crystal structure of europium dichromium icosaaluminum, EuCr2Al20
  30. The crystal structure of N′1,N′3-di((E)-benzylidene) isophthalohydrazide dihydrate, C 22 H 22 N 4 O 4
  31. Crystal structure of 7α,11α-dihydroxy-15-oxo-ent-kauran-16-en-19,6β-olide, C20H26O5
  32. Crystal structure of 4-chloro-N′-[(1E)-pyridin-3-ylmethylidene]benzohydrazide, C13H10ClN3O
  33. The crystal structure of (Z)-3-(1-(2-((E)-4-isopropylbenzylidene)hydrazinyl)ethylidene) chroman-2,4-dione, C21H20N2O3
  34. Crystal structure of E-7-fluoro-2-(2-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C18H12F4O
  35. Crystal structure of bis(6-aminopyridine-2-carboxylato–k2O,N)-bis(N,N-dimethylformamide-k1 O)zinc(II), C18H24N6O6Zn
  36. Crystal structure of 5-(adamantan-1-yl)-3-[(4-{[2-(trifluoromethyl)phenyl]-methyl}piperazin-1-yl)methyl]-1,3,4-oxadiazole-2(3H)-thione, C25H31F3N4OS
  37. Crystal structure of tetrapropylammonium bicarbonate–1-(diaminomethylene)thiourea – water (2/2/1), C30H72N10O7S2
  38. Crystal structure of tris(2,2′-bipyridine-κ2 N,N′)iron(II) triiodide – dichloromethane (2/1), C61H50Cl2Fe2I12N12
  39. Crystal structure of 2-amino-3-[2-(1,3,3-trimethyl-1,3-dihydro-indol-2-ylidene)-ethylideneamino]-but-2-enedinitrile, C17H17N5
  40. The crystal structure of 1-(2-chlorophenyl)-3-cycloheptylurea, C14H19ClN2O
  41. Crystal structure of potassium bis(pentaselenido-κ 2 Se 1,Se 5)palladate(II), K2[Pd(Se5)2]
  42. The crystal structure of 5,10-bis(2-methoxyethyl)-5,10-dihydro-[1,2,3,4]tetrathiocino[5,6-b:8, 7-b′]diindole, C22H22N2O2S4
  43. The crystal structure of 4-(4-iodophenyl)-5H-1,2,3-dithiazole-5-thione, C8H4INS3
  44. Crystal structure of bis{μ2-(4-acetyl-phenoxy)acetato-κ2 O:O′}-bis{μ2-(4-acetyl-phenoxy)acetato-κ3 O,O′:O)- bis{(4-acetyl-phenoxy)acetato-κ2 O,O′}-bis(phenanthrolin-κ2 N,N′)didysprosium(III) tetrahydrate, C84H78N4O28Dy2
  45. Crystal structure of Eu2Pd3.37(1)Zn13.63(1)
  46. Crystal structure of 2-methoxy-4-(methoxy-carbonyl)phenyl 2-chloro-4-fluorobenzoate, C16H12ClFO5
  47. Crystal structure of catena-poly[bis(μ2-dicyanamide-κ2 N:N′)-bis(4-vinylpyridine-κN)-copper(II)], C18H14CuN8
  48. The crystal structure of iguratimod-dimethylformamide (1/1), C17H14N2O6S·C3H7NO
  49. Synthesis and crystal structure of 1-((3R,10S,13S,17S)-10,13-dimethyl-3-(m-tolylamino)hexadecahydro-1H-cyclopenta[α]phenanthren-17-yl)ethan-1-one, C28H41NO
  50. The crystal structure of diaqua-bis(4-bromo-2-formylphenoxy)zinc(II), C14H12Br2O6Zn
  51. The crystal structure of tetra(1-ethylimidazole-κ 1 N)-[μ 4-imidazole-4,5-dicarboxylato-κ 4 O, N, O′, N′]-trioxido-divanadium, C25H33N10O7V2
  52. The crystal structure of (E)-N′-(1-(4-fluorophenyl)propylidene)-2-hydroxybenzohydrazide, C16H15FN2O2
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 2.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2023-0053/html
Button zum nach oben scrollen